14 Best 52-Week High Stocks To Buy According to Analysts
After two years of substantial gains to record highs, exhaustion in the US equity markets is slowly kicking in.
Jazz Pharmaceuticals Plc (JAZZ)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 1,706,469 | $210,151,657 | 7.94% | |
| 2. | Polaris Capital Management Bernard Horn | 1,085,860 | $133,723,659 | -17% | 6.45% |
| 3. | Renaissance Technologies Jim Simons | 1,001,874 | $123,380,783 | -5% | 0.18% |
| 4. | Vestal Point Capital Ryan Wilder | 975,000 | $120,071,250 | +9% | 7.11% |
| 5. | Millennium Management Israel Englander | 611,294 | $75,280,856 | -7% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $119.65 | 12,000 | Officer | 27,932 | 2024-03-01 | Filing | |
| $112.32 | 11,482 | Director | 1,152,788 | 2020-05-27 | Filing | |
| $111.56 | 9,884 | Director | 1,141,306 | 2020-05-27 | Filing | |
| $110.52 | 8,391 | Director | 1,131,422 | 2020-05-27 | Filing | |
| $109.55 | 5,243 | Director | 1,123,031 | 2020-05-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.31 | 1,500 | Officer, Director | 439,744 | 2025-02-03 | Filing | |
| $123.43 | 1,500 | Officer, Director | 425,525 | 2025-01-02 | Filing | |
| $121.17 | 2,000 | Officer, Director | 427,025 | 2024-12-02 | Filing | |
| $122.49 | 53 | Officer | 6,596 | 2024-12-02 | Filing | |
| $123.41 | 3,700 | Officer | 33,048 | 2024-11-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,036,183 | $743,355,936 | 0.01% | |
| 2. | 5,851,226 | $720,578,425 | 0.01% | |
| 3. | 2,214,480 | $272,713,212 | 0.58% | |
| 4. | 2,035,070 | $250,619,068 | 0.06% | |
| 5. | 1,968,822 | $242,460,429 | 0% |
News See All
8 Most Undervalued Pot Stocks to Buy According to Analysts
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational purposes.
Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
Silver Ring Value Partners, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Immunotherapy Stocks to Buy Now
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen. Thank you for standing by. My name is Abbie, and I’ll be your operator today.
8 Best Stocks to Buy for High Returns in 2024
The broader market reached new record highs on October 11, driven by financial stocks posting stronger-than-expected quarterly results. Adding to investor optimism is the recent decline in U.S.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Piper Sandler's Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets. September's second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut.
8 Most Undervalued Growth Stocks To Buy According To Wall Street Analysts
Analysts and the market blamed the Fed for not cutting the interest rate earlier in July. However, the sentiments seemed to have shifted with the recent jobs report with above-expectation data.
7 Best Small-Cap Value Stocks to Buy According to Hedge Funds
Today's AI-fueled era of the "Magnificient Seven" technology stocks is dominating the US stock market. However, investing with a focus on value stocks hasn't lost its popularity.
Billionaire Hedge Funds
